Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 30)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ALNYLAM PHARM -- ALNY1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ALNY , AGEN , CRTX , DVAX , PTN , SGEN , SNMX -- DRUGS3$4  View Abstract
20-Nov-09Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALNYLAM PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.3$20  View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25  View Abstract
13-Nov-09Thomson StreetEventsN/AALNY - Event Transcript of Alnylam Pharmaceuticals conference call, Nov. 12, 2009 / 8:30am ET46$75  View Abstract
11-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Alnylam Pharmaceuticals, Inc.40$65  View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25  View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25  View Abstract
5-Nov-09Thomson StreetEventsN/AALNY - Event Brief of Alnylam Pharmaceuticals conference call, Nov. 04, 2009 / 4:30pm ET24$75  View Abstract
Next 20

Brokerage Reports (Showing 1 to 6 of 6)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
13-Nov-09Thomson StreetEventsN/AALNY - Event Transcript of Alnylam Pharmaceuticals conference call, Nov. 12, 2009 / 8:30am ET46$75  View Abstract
5-Nov-09Thomson StreetEventsN/AALNY - Event Brief of Alnylam Pharmaceuticals conference call, Nov. 04, 2009 / 4:30pm ET24$75  View Abstract
5-Nov-09Thomson StreetEventsN/AALNY - Event Transcript of Alnylam Pharmaceuticals conference call, Nov. 04, 2009 / 4:30pm ET24$75  View Abstract
26-Oct-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary17$50  View Abstract
26-Oct-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoQ3 Earnings Preview28$75 4 Stars View Abstract
12-Oct-09Thomson StreetEventsN/AALNY - Event Transcript of Alnylam Pharmaceuticals conference call, Oct. 06, 2009 / 9:00am ET8$75  View Abstract

Independent Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ALNYLAM PHARM -- ALNY1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ALNY , AGEN , CRTX , DVAX , PTN , SGEN , SNMX -- DRUGS3$4View Abstract
20-Nov-09Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALNYLAM PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.3$20View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25View Abstract
11-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Alnylam Pharmaceuticals, Inc.40$65View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25View Abstract
1-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25View Abstract
25-Oct-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC5$25View Abstract
Next 14

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.